Associate Director, Health Economic Outcomes (Remote)

15 years with 7+ years of Management experience in clinical setting, market access, reimbursement, and/or health economics, with a strong focus on molecular diagnostics.

Experience in designing and implementing cost-effectiveness analyses, budget impact models, and other economic evaluations to support payer negotiations and HTA requirements.

Experience with applying micro costing techniques to capture granular resource utilization and cost data for economic evaluations.

Proven success in market access strategies and partnering in diagnostics, biopharma, or the payer setting.

Understanding of reimbursement systems, HTA processes, and payer decision-making across major markets.

Experience with molecular diagnostics, next-generation sequencing (NGS), and precision medicine applications.

Support global market access strategies for molecular diagnostic solutions including client and ecosystem facing partnerships and internal development processes.

Partner with regional and country Teams to secure reimbursement and access in key markets, addressing diverse payer requirements and Health Technology Assessment processes.

Collaborate with regional Government Affairs, Commercial, Medical Affairs and Marketing Teams to support strategies to gain, protect and expand access to genomic solutions and emerging applications.

Support the definition and communication of clinical and economic value of diagnostics through compelling value propositions, evidence generation studies, and payer engagement and collaboration.

Support the Global Health Economics and Outcomes Team on evidence generation strategies, including clinical utility studies, real-world evidence, and health economic and costing models.

Aid in monitoring global policy coverage trends, rate setting, HTA requirements, and payer expectations related to molecular diagnostic testing to inform strategic planning and product development.